TransMedics Group, Inc. Common Stock
TMDX US89377M1099
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 1% | 203% | 38% | -19% | 4% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Hassanein Waleed H CEO |
116.85 USD |
1,858 Bought |
217,107 USD |
06/08/2025 | 07/08/2025 |
| Hassanein Waleed H CEO |
116.08 USD |
6,617 Bought |
768,101 USD |
06/08/2025 | 07/08/2025 |
| Hassanein Waleed H CEO |
118.68 USD |
8,400 Bought |
996,912 USD |
06/08/2025 | 06/08/2025 |
| Basile Edward M |
125.51 USD |
4,143 Sold |
519,988 USD |
04/08/2025 | 04/08/2025 |
| Ranganath Anil P. O |
139.80 USD |
686 Sold |
95,903 USD |
09/06/2025 | 09/06/2025 |
| Basile Edward M |
126.45 USD |
5,000 Sold |
632,250 USD |
27/05/2025 | 27/05/2025 |
| Weill David |
123.88 USD |
732 Sold |
90,680 USD |
22/05/2025 | 23/05/2025 |
| Basile Edward M |
115.63 USD |
6,000 Sold |
693,780 USD |
09/05/2025 | 09/05/2025 |
| Basile Edward M |
115.63 USD |
6,000 Sold |
693,780 USD |
09/05/2025 | 09/05/2025 |
| Khayal Tamer I CCO |
76.43 USD |
2,407 Sold |
183,967 USD |
03/03/2025 | 03/03/2025 |